Molecular dynamics and combined docking studies for the identification of Zaire ebola virus inhibitors

References

• Andersen, H. C. (1983). Rattle: A “velocity” version of the shake algorithm for molecular dynamics calculations. Journal of Computational Physics, 52(1), 24–34.
   Web of Science ®Google Scholar
• Bah, E. I., Lamah, M.-C., Fletcher, T., Jacob, S. T., Brett-Major, D. M., Sall, A. A., … Fowler, R. A. (2015). Clinical presentation of patients with ebola virus disease in Conakry, Guinea. New England Journal of Medicine, 372(1), 40–47.
   PubMed Web of Science ®Google Scholar
• Bajorath, J. (2002). Integration of virtual and high-throughput screening. Nature Reviews Drug Discovery, 1(11), 882–894.
   PubMed Web of Science ®Google Scholar
• Barcellos, M. P., Santos, C. B. R., Federico, L. B., Almeida, P. F., da Silva, C., & Taft, C. A. (2018). Pharmacophore and structure-based drug design, molecular dynamics and admet/tox studies to design novel potential pad4 inhibitors. Journal of Biomolecular Structure and Dynamics, 12, 1–16.
   Google Scholar
• Biovia, D. S. (2015). Discovery studio modeling environment. San Diego, CA: Dassault Systèmes.
   Google Scholar
• Bjarne, K. ,& Thomas, K. (2016). CLC drug discovery workbench. Retrieved from http://www.clcsupport.com/clcdrugdiscoveryworkbench/current/User_Manual.pdf
   Google Scholar
• Brown, C. S., Lee, M. S., Leung, D. W., Wang, T., Xu, W., Luthra, P., … Amarasinghe, G. K. (2014). In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity. Journal of Molecular Biology, 426(10), 2045–2058.
   PubMed Web of Science ®Google Scholar
• Bukreyev, A. A., Chandran, K., Dolnik, O., Dye, J. M., Ebihara, H., Leroy, E. M., … Kuhn, J. H. (2014). Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Archives of Virology, 159(4), 821–830.
   PubMed Web of Science ®Google Scholar
• Camp, D., Garavelas, A., & Campitelli, M. (2015). Analysis of physicochemical properties for drugs of natural origin. Journal of Natural Products, 78, 1370–1382.
   PubMed Web of Science ®Google Scholar
• Cavuturu, B. M., Bhandare, V. V., Ramaswamy, A., & Arumugam, N. (2018). Molecular dynamics of interaction of Sesamin and related compounds with the cancer marker β-catenin: An in silico study. Journal of Biomolecular Structure and Dynamics, 12, 1–15.
   Google Scholar
• Cerqueira, N. M. F. S. A., Gesto, D., Oliveira, E. F., Santos-Martins, D., Brás, N. F., Sousa, S. F., … Ramos, M. J. (2015). Receptor-based virtual screening protocol for drug discovery. Archives of Biochemistry and Biophysics, 582, 56–67.
   PubMed Web of Science ®Google Scholar
• Choi, J. H., Jonsson-Schmunk, K., Qiu, X., Shedlock, D. J., Strong, J., Xu, J. X., … Croyle, M. A. (2015). A single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal ebola infection. Molecular Pharmaceutics, 12(8), 2712–2731.
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 1–13.
   PubMed Web of Science ®Google Scholar
• Delgado-Soler, L., Ariñez-Soriano, J., Granadino-Roldán, J. M., & Rubio-Martinez, J. (2011). Predicting binding energies of CDK6 inhibitors in the hit-to-lead process. Theoretical Chemistry Accounts, 128(4-6), 807–823.
   Web of Science ®Google Scholar
• Feher, M. (2006). Consensus scoring for protein-ligand interactions. Drug Discovery Today, 11(9-10), 421–428.
   PubMed Web of Science ®Google Scholar
• Feldmann, H., Geisbert, T. W. (2011). Ebola haemorrhagic fever. Lancet, 377(9768), 849–862.
   PubMed Web of Science ®Google Scholar
• Genheden, S., & Ryde, U. (2015). Expert opinion on drug discovery the MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449.
   PubMed Web of Science ®Google Scholar
• Grard, G., Biek, R., Muyembe Tamfum, J.-J., Fair, J., Wolfe, N., Formenty, P., … Leroy, E. (2011). Emergence of divergent Zaire Ebola virus strains in Democratic Republic of the Congo in 2007 and 2008. Journal of Infectious Diseases, 204(Suppl. 3), S776–S784.
   PubMedGoogle Scholar
• Haasnoot, J., de Vries, W., Geutjes, E.-J., Prins, M., de Haan, P., & Berkhout, B. (2007). The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathogens, 3(6), e86.
   PubMed Web of Science ®Google Scholar
• Hajduk, P. J., Huth, J. R., & Tse, C. (2005). Predicting protein druggability. Drug Discovery Today, 10(23-24), 1675–1682.
   PubMed Web of Science ®Google Scholar
• Hooft, R. W., Sander, C., & Vriend, G. (1997). Objectively judging the quality of a protein structure from a Ramachandran plot. Computer Applications in the Biosciences, 13(4), 425–430.
   PubMedGoogle Scholar
• Hopkins, A. L., Groom, C. R., & Alex, A. (2004). Ligand efficiency: A useful metric for lead selection. Drug Discovery Today, 9(10), 430–431.
   PubMed Web of Science ®Google Scholar
• Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011). Principles of early drug discovery. British Journal of Pharmacology, 162(6), 1239–1249.
   PubMed Web of Science ®Google Scholar
• Islam, M. A., & Pillay, T. S. (2018). β-secretase inhibitors for Alzheimer’s disease: Identification using pharmacoinformatics. Journal of Biomolecular Structure and Dynamics, 1, 1–20.
   Google Scholar
• Jedrzejas, M. J., Singh, S., Brouillette, W. J., Air, G. M., & Luo, M. (1995). A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase. Proteins: Structure, Function, and Genetics, 23(2), 264–277.
   PubMed Web of Science ®Google Scholar
• Kapetanovic, I. M. (2008). Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach. Chemico-Biological Interactions, 171(2), 165–176.
   PubMed Web of Science ®Google Scholar
• Kiss, R., Sandor, M., & Szalai, F. A. (2012). A public web service for drug discovery. Journal of Cheminformatics, 1(4 Suppl.), P17.
   Google Scholar
• Kleywegt, G. J., & Jones, T. A. (1996). Phi/Psi-chology: Ramachandran revisited. Structure, 4(12), 1395–1400.
   PubMed Web of Science ®Google Scholar
• Kuhn, J. H., Becker, S., Ebihara, H., Geisbert, T. W., Johnson, K. M., Kawaoka, Y., … Jahrling, P. B. (2010). Proposal for a revised taxonomy of the family Filoviridae: Classification, names of taxa and viruses, and virus abbreviations. Archives of Virology, 155(12), 2083–2103. doi: 10.1007/s00705-010-0814-x
   PubMed Web of Science ®Google Scholar
• Leung, D. W., Shabman, R. S., Farahbakhsh, M., Prins, K. C., Borek, D. M., Wang, T., … Amarasinghe, G. K. (2010). Structural and functional characterization of reston ebola virus VP35 interferon inhibitory domain. Journal of Molecular Biology, 399(3), 347–357.
   PubMed Web of Science ®Google Scholar
• Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins: Structure, Function, and Bioinformatics, 78, 1950–1958.
   Web of Science ®Google Scholar
• Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235–249.
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337–341.
   PubMedGoogle Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1-3), 3–26.
   Web of Science ®Google Scholar
• Lovell, S. C., Davis, I. W., Arendall, W. B., de Bakker, P. I. W., Word, J. M., Prisant, M. G., … Richardson, D. C. (2003). Structure validation by Cα geometry: ϕ, ψ and Cβ deviation. Proteins: Structure, Function, and Bioinformatics, 50(3), 437–450.
   PubMed Web of Science ®Google Scholar
• Mirza, M. U., & Ikram, N. (2016). Integrated computational approach for virtual hit identification against ebola viral proteins VP35 and VP40. International Journal of Molecular Sciences, 17(11), 1748.
   Web of Science ®Google Scholar
• Olsson, M. H. M., Søndergaard, C. R., Rostkowski, M., & Jensen, J. H. (2011). PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions. Journal of Chemical Theory and Computation, 7(2), 525–537.
   PubMed Web of Science ®Google Scholar
• Onawole, A. T., Kolapo, T. U., Sulaiman, K. O., & Adegoke, R. O. (2018). Structure based virtual screening of the Ebola virus trimeric glycoprotein using consensus scoring. Computational Biology and Chemistry, 72, 170–180.
   PubMed Web of Science ®Google Scholar
• Onawole, A. T., Sulaiman, K. O., Adegoke, R. O., & Kolapo, T. U. (2017). Identification of potential inhibitors against the Zika virus using consensus scoring. Journal of Molecular Graphics and Modelling, 73, 54–61.
   PubMed Web of Science ®Google Scholar
• Pecina, A., Haldar, S., Fanfrlik, J., Meier, R., Řezáč, J., Lepsik, M., & Hobza, P. (2017). The SQM/COSMO Scoring Function at the DFTB3-D3H4 Level: unique identification of native protein-ligand poses. Journal of Chemical Information and Modeling, 57(2), 127–132.
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072.
   PubMed Web of Science ®Google Scholar
• Polanski, J., Tkocz, A., & Kucia, U. (2017). Beware of ligand efficiency (LE): Understanding LE data in modeling structure—Activity and structure—Economy relationships. Journal of Cheminformatics, 9(1), 48–49.
   PubMedGoogle Scholar
• Prada-Gracia, D., Huerta-Yépez, S., & Moreno-Vargas, L. M. (2016). Application of computational methods for anticancer drug discovery, design, and optimization. Boletín Médico Del Hospital Infantil De México, 73(6), 411–423.
   PubMed Web of Science ®Google Scholar
• Radchenko, E. V., Dyabina, A. S., Palyulin, V. A., & Zefirov, N. S. (2016). Prediction of human intestinal absorption of drug compounds from molecular structure. Russian Chemical Bulletin, 65(2), 576–580.
   Web of Science ®Google Scholar
• Ramachandran, G. N., & Sasisekharan, V. (1968). Conformation of polypeptides and proteins. Advances in Protein Chemistry, 23, 283–437.
   PubMedGoogle Scholar
• Ren, J.-X., Zhang, R.-T., Zhang, H., Cao, X.-S., Liu, L.-K., & Xie, Y. (2016). Identification of novel VP35 inhibitors: virtual screening driven new scaffolds. Biomedicine & Pharmacotherapy, 84, 199–207.
   PubMed Web of Science ®Google Scholar
• Reynolds, C. H., & Reynolds, R. C. (2017). Group additivity in ligand binding affinity: An alternative approach to ligand efficiency. Journal of Chemical Information and Modeling, 57(12), 3086–3096.
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095.
   PubMed Web of Science ®Google Scholar
• Salomon-Ferrer, R., Case, D. A., & Walker, R. C. (2013). An overview of the Amber biomolecular simulation package. Wiley Interdisciplinary Reviews: Computational Molecular Science, 3(2), 198–210.
   Web of Science ®Google Scholar
• Sanguinetti, M. C., & Tristani-Firouzi, M. (2006). hERG potassium channels and cardiac arrhythmia. Nature, 440(7083), 463–469.
   PubMed Web of Science ®Google Scholar
• Schwede, T. (2013). Homology modeling of protein structures. In Encyclopedia of biophysics (pp. 992–998). Berlin, Heidelberg: Springer Berlin Heidelberg.
   Google Scholar
• Setlur, A. S., Naik, S. Y., & Skariyachan, S. (2017). Herbal lead as ideal bioactive compounds against probable drug targets of ebola virus in comparison with known chemical analogue: A computational drug discovery perspective. Interdisciplinary Sciences: Computational Life Sciences, 9(2), 254–277.
   Google Scholar
• Srinivasan, B., Zhou, H., Kubanek, J., & Skolnick, J. (2014). Experimental validation of FINDSITE comb virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders. Journal of Cheminformatics, 6(1), 14–16.
   PubMedGoogle Scholar
• The World Bank. (2015, August). GDP growth (annual %). Retrieved from http://doi.org/10.1016/S2214-109X(15)00065-0
   Google Scholar
• Toropov, A. A., Toropova, A. P., Beeg, M., Gobbi, M., & Salmona, M. (2017). QSAR model for blood-brain barrier permeation. Journal of Pharmacological and Toxicological Methods, 88, 7–18.
   PubMed Web of Science ®Google Scholar
• Tosh, P. K., Sampathkumar, P., & Feldmann, H. (2014). What clinicians should know about the 2014 Ebola outbreak. Mayo Clinic Proceedings, 89(12), 1710–1717.
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry, 31, 455–461.
   Web of Science ®Google Scholar
• Tsaioun, K., & Kates, S. (2011). ADMET for medicinal chemists: A practical guide. Hoboken, NJ: Wiley.
   Google Scholar
• Villaseñor-Granados, T., García, S., Vazquez, M. A., & Robles, J. (2016). Molecular docking-based screening of newly designed coumarin derivatives with potential antifungal activity against lanosterol 14 α-demethylase. Theoretical Chemistry Accounts, 135(9), 210.
   Web of Science ®Google Scholar
• Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics and Modelling, 25(2), 247–260.
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174.
   PubMed Web of Science ®Google Scholar
• Wang, Z., Sun, H., Yao, X., Li, D., Xu, L., Li, Y., … Hou, T. (2016). Comprehensive evaluation of ten docking programs on a diverse set of protein–ligand complexes: The prediction accuracy of sampling power and scoring power. Physical Chemistry Chemical Physics, 18(18), 12964–12975.
   PubMed Web of Science ®Google Scholar
• Wessel, M. D., Jurs, P. C., Tolan, J. W., & Muskal, S. M. (1998). Prediction of human intestinal absorption of drug compounds from molecular structure. Journal of Chemical Information and Computer Sciences, 38(4), 726–735.
   PubMedGoogle Scholar
• Weyer, J., Grobbelaar, A., & Blumberg, L. (2015). Ebola virus disease: History, epidemiology and outbreaks. Current Infectious Disease Reports, 17(5), 21.
   Web of Science ®Google Scholar
• WHO. (1978). Ebola haemorrhagic fever in Zaire, 1976. Bulletin of the World Health Organisation, 56(October 1976), 271–293.
   PubMedGoogle Scholar
• WHO (WHO Director-General briefs media on outcome of Ebola Emergency Committee). (2016). WHO. Retrieved from http://www.who.int/mediacentre/news/statements/2016/ihr-emergency-committee-ebola/en/
   Google Scholar
• Wildman, S. A., & Crippen, G. M. (1999). Prediction of physicochemical parameters by atomic contributions. Journal of Chemical Information and Modeling, 39, 868–873.
   Google Scholar
• Xu, W., Lucke, A. J., & Fairlie, D. P. (2015). Comparing sixteen scoring functions for predicting biological activities of ligands for protein targets. Journal of Molecular Graphics and Modelling, 57, 76–88.
   PubMed Web of Science ®Google Scholar
• Ye, L., & Yang, C. (2015). Development of vaccines for prevention of Ebola virus infection. Microbes and Infection, 17(2), 98–108.
   PubMed Web of Science ®Google Scholar
• Zheng, M., Zhao, J., Cui, C., Fu, Z., Li, X., Liu, X., … Jiang, H. (2018). Computational chemical biology and drug design: Facilitating protein structure, function, and modulation studies. Medicinal Research Reviews, 38(3), 914–950.
   PubMed Web of Science ®Google Scholar